RedHill Biopharma Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
RDHL
IL0011223810
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | -9.57% | -17.72% |
Sales 2022 | 61.8M 23.14B 5.16B | Sales 2023 | 6.53M 2.45B 545M | Capitalization | 28.72M 10.76B 2.4B |
---|---|---|---|---|---|
Net income 2022 | -71M -26.59B -5.92B | Net income 2023 | 23M 8.61B 1.92B | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 38.46B 8.57B | Net cash position 2023 | 4.4M 1.65B 367M | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03/09/03 |
Ori Shilo
FOU | Founder | 58 | 03/09/03 |
Razi Ingber
DFI | Director of Finance/CFO | - | 05/23/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 01/16/01 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 26/10/26 |
Director/Board Member | 80 | 03/10/03 |
1st Jan change | Capi. | |
---|---|---|
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-16.48% | 31.47B | |
+54.18% | 25.24B | |
-13.58% | 15.82B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+5.32% | 8.84B | |
-2.11% | 7.93B |
- Stock Market
- Equities
- RDHL Stock
- RDHL Stock